ArticleThoracic cancer2020

EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.

Leticia F Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.